Utilizing multiple loss-of-function shRNA screens, we analyzed the effects on phenotypically different tumor subpopulations and identified cyclin-dependent kinase 4/retinoblastoma protein (CDK4/RB) as a major survival pathway in mesenchymal cell–like tumor cells. Here, CDK4 is linked to neoplasm.